University of the Balearic Islands spinout Sanifit has raised $62.8m in a series D round backed by existing backer Lundbeckfonden Ventures to bring its overall financing to $149m.

Sanifit, a Spain-based vascular calcification medicine spinout of University of the Balearic Islands, closed a €55.2m ($62.8m) series D round on Wednesday featuring Lundbeckfonden Ventures, the corporate venturing arm of pharmaceutical firm Lundbeck.
The round was led by Caixa Capital Risc, the venture capital vehicle for financial services firm La Caixa, and also featured Columbus Venture Partners, Alta Life Sciences, Ysios Capital, HealthEquity, Forbion Capital Partners, Gilde Healthcare, Andera Partners and unnamed private investors.
The company claims the…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?